Erin E. Kershaw MD Tackles Obesity and Associated Disorders
In her position as Chief of the Division of Endocrinology and Metabolism, Erin E. Kershaw MD works at the forefront of a global fight against rising rates of obesity, diabetes, and other complications associated with being overweight.
Appointed Division Chief in July 2016, Dr. Kershaw said her academic mission is to combine basic and translational research with clinical expertise to expand the understanding and treatment of obesity and its related metabolic disorders.
Her clinical interests, meanwhile, center on disorders of “fat,” including obesity, insulin resistance, diabetes, and metabolic syndrome as well as pre- and post-operative care for bariatric surgery patients.
During Dr. Kershaw’s medical studies at Cornell University Medical College, New York, she was awarded a prestigious Howard Hughes Medical Institute Fellowship for research in the laboratory of Rudolph L. Leibel at the Rockefeller University in New York. She studied the molecular genetic basis for type 2 diabetes in obese rodents.
Dr. Kershaw graduated from medical schools with honors in research in 1997. She completed her medical sub specialty fellowship in Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess Medical Center, Joslin Diabetes Center, and Harvard Medical School, Boston.
While at Harvard, she worked in the laboratory of Jeffrey S. Flier where her research focused on the role of intracellular lipid and steroid metabolism in the metabolic syndrome. She was subsequently promoted to faculty at Beth Israel Deaconess Medical Center and Harvard Medical School prior to joining the faculty at the University of Pittsburgh in 2007.